Published: 2020-11-19 08:55 | Updated: 2020-11-19 08:58

Current calls, week 47, 2020

Tips from KI Grants Office about current calls

Swedish and Nordic calls

Anslag till blodcancerforskning – Blodcancerförbundet

Blodcancerförbundet inbjuder ansökningar om forskningsanslag. Dessa stöder forskning och utveckling inom blodcancer. Sökande ska vara personal verksamma vid hematologiska kliniker. Anslag ges inte till personer verksamma inom barnonkologi och barnhematologi. Budgeten är SEK 1,5 miljoner.

Closing date:1 December 2020

Further information

Forskning relaterad till Covid-19 och blodcancer – Blodcancerförbundet

Blodcancerförbundet inbjuder ansökningar om medel för forskning relaterad till Covid-19. Dessa stöder forskning relaterad till Covid-19 och blodcancer. Behöriga att söka är personal verksamma vid hematologiska kliniker. Personer verksamma inom barnonkologi och barnhematologi kan inte söka. Den totala budgeten är SEK 800,000.

Closing date:1 December 2020

Further information

Research in long-term health consequences of COVID-19 illness – Novo Nordisk Foundation

Novo Nordisk Foundation invites applications for its research in long-term health consequences of COVID-19 illness call. This supports collaborative projects that investigate the nature, incidence, distribution of long-term symptoms, and their underlying pathogenesis in COVID-19 patients as well as the development and testing of treatments for long-term COVID-19 illness.

Research groups of up to five may apply. The main applicant should be employed at a Danish hospital, university, or other non-profit research organisation. The research institutions of the co-applicants can be in Denmark or abroad. A total of up to DKK 40 million is available for grants between DKK 3m and DKK 10m for projects lasting up to four years.

Closing date:12 January 2021

Further information

Bidrag till hjärnforskning – Märta Lundqvist Foundation

Märta Lundqvists Stiftelse inbjuder ansökningar om bidrag till hjärnforskning. Dessa stöder forskning vid svenska universitet som är relaterad till den mänskliga hjärnans område. Prioritet ges till patientrelaterad och kliniskt fokuserad forskning. Forskare vid svenska universitet med avlagd doktorsexamen efter 1 januari 2016 kan söka. Avräkning av tid kan ske för föräldraledighet och tid för eventuell AT tjänst.

Closing date:13 January 2021

Further information

Letten prize – Letten Foundation

The Letten Foundation and the Young Academy of Norway invite applications for their Letten prize. This recognises young researchers’ contributions in the fields of health, development, environment and equality in all aspects of human life. Applicants must have conducted research of great societal relevance, and be under 45 years old the year when the prize is awarded. Researchers who have conducted research which has impact across national boarders, or are engaged in interdisciplinary research, are encouraged to apply. The prize is worth NOK 2 million, of which one fourth of the award amount is for personal usage and the remaining sum is to be used for research activities.

Closing date: 2 February 2021

Further information

Ledamöter till Sveriges Unga Akademi (SUA) för inval 2021

Som ledamot i SUA får man tillgång till ett forum där ett urval av Sveriges ledande yngre forskare möts för att diskutera och driva frågor som i vid mening berör forskning och vetenskap. Beroende på intressen ges möjlighet att till exempel engageras sig i forskningspolitiskt påverkansarbete, utveckla sin förmåga till populärvetenskaplig kommunikation, inspirera barn och unga att bry sig om vetenskap, och växa i rollen som akademisk ledare.

Sveriges unga akademi är en tvärvetenskaplig akademi för ett urval av de bästa yngre forskarna i Sverige, med en verksamhet som vilar på fyra ben: forskningspolitik, internationalisering, tvärvetenskap och utåtriktade aktiviteter. Akademin är en oberoende plattform som bildades på initiativ av Kungl. Vetenskapsakademien 2011 och har mellan 35 och 40 ledamöter.  Forskare som disputerat för maximalt tio år sedan är välkomna att söka.

Further information

European calls

Health professionals research grant - European League Against Rheumatism

The European League Against Rheumatism invites applications for its health professionals research grant. This supports a research project undertaken by a health professional in the field of rheumatic and musculoskeletal diseases.

The project must involve partners from at least three European countries and the project leader should have experience and academic credentials of relevance to the proposed study. The project must be in line with the mission, objectives and goals of EULAR. One award, worth up to €30,000 is available.

Closing date: 15 December 2020

Further information

Call for research proposals on psoriatic arthritis - Foundation for Research in Rheumatology

The Foundation for Research in Rheumatology invites letters of intent for its call on psoriatic arthritis (PsA). This supports innovative projects aimed at increasing understanding of PsA in order to instigate research into this disease in Europe. Support is available for projects in the following areas:

  • studies that improve understanding of the pathophysiology of PsA and help to define the nature of its various disease manifestations;
  • investigations that allow better characterisation of the different disease stages and subsets of PsA;
  • development of methods that help to define the disease course of PsA;
  • concepts that improve the overall management of PsA patients;
  • approaches that foster the development or implementation of ful methods for comprehensively monitoring disease activity and the functional state of PsA patients.

Applications must involve partners from at least different European countries. Applicants must come from a European League Against Rheumatism member country. Funding is worth up to €600,000 per project for a maximum of three years.

Closing date: 1 January 2021

Further information

Daniel Alagille award - European Association for the Study of the Liver

The European Association for the Study of the Liver invites applications for the Daniel Alagille award. This supports a young investigator conducting a biomedical research project in the field of paediatric and adult genetic cholestatic diseases sharing mutual disease-causing mechanisms.

Applicants must hold a MD or PhD degree and be no more than 40 years old. They should hold a full time position within their institution and should be working in a European institution and be EASL members.The award is worth €25,000. A travel award to the international liver congress worth €1,000 is also included.

Closing date: 15 December 2020

Further information

Grants for innovative diabetic foot ulcer projects - European Wound Management Association

The European Wound Management Association, supported by Urgo Medical, invites applications for its grants for innovative diabetic foot ulcer projects. These support innovative projects that improve diabetic food ulcer prevention and management. Projects may be submitted by any researchers or healthcare professionals working in the field, including specialists, caregivers and multidisciplinary teams. Both early-career and senior professionals may apply.

Two grants, worth up to €10,000 each, are available for up to one year to cover salary expenses, direct operating costs, equipment and devices, travel expenses, dissemination of knowledge and non-scientific, administrative expenses.

Closing date: 20 December 2020

Further information

US calls

Federal Funding agencies

NINDS Exploratory Neuroscience Research Grant (R21- Clinical Trial Optional), NIH

The National Institute of Neurological Disorders and Stroke and the National Institute of Mental Health invite applications for their exploratory neuroscience research grant (R21 clinical trial optional) funding opportunity. The NINDS Exploratory Neuroscience Research Grant program supports exploratory and innovative research projects, which fall within the mission of the NINDS. Awards will provide support for the early and conceptual stages of projects. These studies often assess the feasibility of a novel avenue of investigation and involve considerable risk, but have the potential to bring about breakthroughs in the understanding of important areas of neuroscience, or to the development of novel techniques, agents, methodologies, or models, of high value to the neuroscience community.  

Budget: Grants are worth up to USD 275,000 in direct costs over two years, with no more than USD 200,000 in direct costs allowed in any single year. The maximum project period is two years.   

Closing date: Standard dates apply, by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PA-18-358

Further information 

Advancing genomic medicine research (R21 clinical trial optional), NIH

The National Human Genome Research Institute invites applications for its advancing genomic medicine research (R21 clinical trial optional) funding opportunity. This Funding Opportunity Announcement (FOA) encourages applications that stimulate innovation and advance understanding of when, where, and how best to implement the use of genomic information and technologies in clinical care. Proposed projects should be broadly applicable to genomic medicine as a field, and yield findings of significance beyond a single disease, gene, or setting. Projects are strongly encouraged to include ancestrally diverse and underrepresented participants and populations.

Closing date: March 8, 2021; November 2, 2021; August 1, 2022; March 13, 2023.

Funding Opportunity Announcement (FOA): RFA-HG-20-037

Further information 

Extracellular RNA carrier subclasses in processes relevant to substance use disorders or HIV infection (R01; R21 clinical trial not allowed), NIH

The purpose of this FOA is to encourage research investigating the roles of extracellular RNA (exRNA) carrier subclasses in biological processes relevant to substance use disorders (SUDs) and/or HIV infection, latency, or pathogenesis in the CNS. Applicants may propose to investigate biological mechanisms involving exRNA carrier subclasses, or propose to develop improved technologies to investigate extracellular vesicles or other exRNA carriers.

Closing date: March 15, 2021, October 13, 2021, March 15, 2022, October 13, 2022, March 15, 2023

All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-20-148

Related Funding Opportunity Announcement (FOA): PAR-20-147 (R01), PAR-20-148 (R21)

Further information (R01)

Further information (R21)   


Hollis Brownstein research grants, Leukemia Research Foundation, US

The Leukemia Research Foundation invites letters of intent for the Hollis Brownstein research grants. These support new investigators who are beginning to establish their own laboratories that are no longer under the tutelage of a senior scientist mentor. Preference is given to proposals that focus on leukemia, lymphoma, myelodysplastic syndrome and multiple myeloma.

  • The Leukemia Research Foundation does not provide funds for capital equipment (i.e. equipment purchases in excess of $5,000). Any request for exception to this policy must detail clearly the specific need of the capital equipment for the proposed research project.
  • The Leukemia Research Foundation does not provide salary support for the principal investigator.
  • Using funds for research travel is permitted but should not exceed $1,000. This money is intended only to enhance the study.
  • The Leukemia Research Foundation does not provide indirect cost recovery or institutional overhead costs.

Eligibility: New Investigators are considered to be within seven years of their first independent faculty-level position at the time the grant would be awarded. Years as a resident physician, fellow physician, or post-doctoral fellow are considered to be training years. Investigator must be in an independent faculty-level position at the time the application is submitted.

Budget: Grants are each worth up to USD 100,000 over one year.

Closing date: Letters of intent are invited between 30 October 2020 and 12 midnight central standard time, 5 February 2021; full applications are invited between 5 March and 11.59pm central standard time, 5 April 2021. This call is repeated once a year.

Further information 

Irvington postdoctoral fellowships, Cancer Research Institute, US

The Cancer Research Institute (CRI) invites applications for the Irvington postdoctoral fellowships. These support young scientists at universities and research centres worldwide who wish to receive training in cancer immunology.

Eligibility: Applicants must be working in areas directly related to immunology or cancer immunology. They must have a doctoral degree and less than five years’ relevant postdoctoral experience, with the exception of MD applicants. Projects must be conducted under a sponsor who holds a formal appointment at the host institution. There are no citizenship restrictions.

Budget: Fellowships are worth USD 175,500 each over three years. Funding may cover salary, health insurance, travel expenses and other research-related costs.

Closing date: April 1, 2021; October 1, 2021.

Further information